Roughly 1 in every 167 people worldwide carries AB negative blood, making it the rarest of the eight standard ABO/Rh blood types at well under 1% of the global population. The exact share shifts depending on where you look, from virtually absent in parts of sub-Saharan Africa and East Asia to slightly more common in certain European populations, but nowhere does AB negative come close to common. That rarity creates real challenges for blood banks, emergency rooms, and pregnancies, and it has roots in an evolutionary story stretching back millions of years.
Why AB Negative Is the Rarest Type
Two independent genetic systems have to line up in the least likely way for someone to end up AB negative. The ABO system sorts people into A, B, AB, or O based on which sugar molecules sit on the surface of their red blood cells. AB requires a person to inherit one A-type gene variant from one parent and one B-type variant from the other. Since both A and B are individually less common than O in most populations, inheriting one of each is already an unlikely draw. In many regions, only about 3 to 5% of people are AB of any Rh type.
Then the Rh system has to cooperate. Most people are Rh positive, meaning their red cells carry the RhD protein. Globally, only about 15% of people are Rh negative, and in many non-European populations the figure is far lower. When you multiply the small probability of being AB by the small probability of being Rh negative, the result is the sliver of the population that falls into AB negative territory.
How the Numbers Shift Around the World
Population genetics makes AB negative more common in some regions and almost nonexistent in others. In the United States, where the population is ethnically mixed, about 0.6% of people are AB negative. In Western Europe, the proportion edges slightly higher in some countries because Rh negativity is more common among people of European descent. Among Basque populations in Spain and France, for example, the frequency of the RhD-negative gene variant reaches about 47%, far higher than in any other studied group, which means Rh-negative types of all ABO categories show up at elevated rates there.1PubMed Central. Sequence diversity of the Rh blood group system in Basques
In sub-Saharan Africa, by contrast, Rh negativity is rare. A study of blood group frequencies across ethnic groups in Ghana’s Volta region found that AB negative accounted for less than 1% of every group examined, making it the least common type in a region where O positive dominates at over 35%.2PubMed Central. Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services Similar patterns hold across much of East Asia and Indigenous populations of the Americas, where Rh negativity can be nearly absent. Japan, for instance, has extremely low rates of Rh-negative blood of any ABO type.
These regional differences are not random. They reflect millennia of population history, migration patterns, and natural selection pressures acting on both the ABO and Rh gene families independently.
What AB Negative Means for Blood Banks
If you have AB negative blood and need a red blood cell transfusion, you can receive red cells from any Rh-negative donor: O negative, A negative, B negative, or AB negative. That flexibility helps, because finding a bag of AB negative red cells in a hospital refrigerator is a long shot. Blood banks generally stock types in proportion to demand, and AB negative patients are so rare that keeping a large inventory on hand does not make logistical sense. In practice, AB negative patients receiving red cells will most often get O negative, the universal red cell donor type.
The more interesting supply problem runs in the other direction. AB negative and AB positive plasma is considered universal donor plasma. Because AB plasma lacks both anti-A and anti-B antibodies, it can be given safely to patients of any ABO type without triggering a reaction. This makes AB plasma particularly valuable in trauma centers, where injured patients arrive needing emergency plasma before their blood type is even known.
The AB Plasma Shortage and Workarounds
Since fewer than 4% of people in most countries are AB of any Rh type, the supply of AB plasma is chronically limited. Trauma centers that follow traditional protocols calling for AB plasma in emergencies can burn through their stock quickly. A multicenter study comparing emergency-release group A plasma with group AB plasma in blunt-trauma patients found that group A plasma was a safe alternative, with no increase in adverse reactions.3PubMed Central. Multicenter Comparison of Emergency Release Group A versus AB Plasma in Blunt‐Injured Trauma Patients Group A plasma is much easier for blood banks to keep in stock because group A donors are far more common in the general population.4PubMed Central. Group A emergency release plasma in trauma patients requiring massive transfusion
That said, a systematic review of the available studies cautioned that the evidence base remains small, and further research is needed before universal recommendations can be made about replacing AB plasma entirely.5PubMed. Are there any alternatives for transfusion of AB plasma as universal donor in an emergency release setting? Many hospitals have already shifted toward using group A plasma in emergencies, though policies vary. If you are AB negative, your plasma donations are especially valuable precisely because so few people share your type.
Pregnancy Complications for Rh-Negative Women
The “negative” in AB negative carries specific medical significance beyond transfusion. Any Rh-negative woman, including those with AB negative blood, faces a potential complication during pregnancy if her baby is Rh positive. When small amounts of fetal blood cross the placenta, the mother’s immune system can recognize the RhD protein as foreign and start producing antibodies against it.6PubMed Central. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation In a first pregnancy, this sensitization usually does not cause problems. But in subsequent pregnancies with another Rh-positive baby, those antibodies can cross the placenta and attack the fetal red blood cells, leading to hemolytic disease that can cause severe anemia, organ damage, or fetal death if untreated.7INDIAN JOURNAL OF APPLIED RESEARCH. MATERNAL AND FETAL OUTCOME IN RH NEGATIVE PREGNANCY
The standard preventive treatment is an injection of anti-D immunoglobulin (commonly known by the brand name RhoGAM) given during pregnancy and after delivery. This treatment effectively prevents the mother’s immune system from becoming sensitized. In developed countries with routine prenatal screening, Rh disease has become rare, but it remains a serious concern in parts of the world where access to anti-D immunoglobulin is limited. For AB negative women specifically, there is no additional pregnancy risk from the AB part of their type; the concern is entirely about the Rh factor.
Blood Type and Disease Risk
Researchers have spent decades studying whether blood type influences susceptibility to certain diseases. The most consistent finding is that people with non-O blood types, including AB, face a somewhat higher risk of blood clotting disorders. A large study of 1.5 million blood donors found that non-O groups were associated with a higher incidence of both venous and arterial clotting events compared to group O.8PubMed. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors Genome-wide association studies have also identified the ABO gene region as a risk locus for heart attack and other cardiovascular events, reinforcing earlier observational work.9PubMed Central. ABO Blood Groups and Cardiovascular Diseases
Before anyone with AB negative blood panics, though, the effect size is modest. Blood type is one variable among dozens that influence cardiovascular risk, and it is far less important than smoking, high blood pressure, cholesterol levels, or physical inactivity. Knowing your blood type does not change your treatment plan or screening schedule in any meaningful way. Some smaller studies have looked at whether the specific combination of ABO and Rh status matters for cardiovascular risk factors like diabetes and abnormal cholesterol, but findings have been inconsistent. One hospital-based study found no significant difference in the distribution of major cardiovascular risk factors across ABO groups.10Indian Journal of Cardiovascular Disease in Women WINCARS. ABO Blood Group System and the Association with Cardiovascular Risk Factors between Men and Women with Cardiovascular Diseases—A Comparative Study
There have also been studies linking blood type to stomach cancer risk, pancreatic cancer, and susceptibility to certain infections, but these associations are generally small and do not single out AB negative specifically. The Rh-negative component does not appear to carry independent disease risk beyond the pregnancy complications already discussed.
Why Blood Group O Dominates and AB Does Not
The fact that AB is the rarest ABO group in nearly every population is not just a statistical accident. Natural selection appears to have played a role, and one of the most studied mechanisms involves malaria. Research has shown that blood group O provides a degree of protection against severe malaria caused by the parasite Plasmodium falciparum.11PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting The parasite causes infected red blood cells to clump together with uninfected ones in a process called rosetting, and this clumping happens less easily with group O cells. People who carry two copies of non-O gene variants appear to face a greater risk of severe malaria than those who carry just one, suggesting a dose effect.12PLOS Genetics. Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria
In regions where malaria has been endemic for thousands of years, this selection pressure has pushed the frequency of group O upward. A broad review of the evidence concluded that the global distribution and relative proportions of ABO groups have likely been shaped by malaria.13PubMed. The ABO blood group system and Plasmodium falciparum malaria Because AB individuals carry both A and B antigens and no O-type protection, they sit at the losing end of this selection in malaria-endemic areas, which helps explain why AB frequencies are lowest in tropical Africa and highest in Central and East Asia, where the selection pressures differed.
The ABO polymorphism itself is ancient. A comparative genetics study found that the A and B blood group variants are not unique to humans but are shared across primates, including gibbons and Old World monkeys, through a common ancestral gene. This means the A/B distinction has been maintained under balancing selection for tens of millions of years, making it one of the longest-running examples of such selection outside of immune system genes.14PubMed Central. The ABO blood group is a trans-species polymorphism in primates Whatever forces keep both A and B alleles circulating have been at work since before humans existed as a species, which means AB individuals have been a rare but persistent feature of primate biology for a very long time.
When AB Is Not Quite AB
Blood typing is usually straightforward, but AB can occasionally be more complicated than it looks. One unusual variant called cis-AB occurs when a single gene produces an enzyme with both A and B activity, meaning a person can type as AB even though both antigens were inherited from the same parent rather than one from each. Cis-AB is the most common ABO subgroup in Korea and appears more frequently in East Asia than elsewhere.15PubMed Central. Cis-AB, the Blood Group of Many Faces, Is a Conundrum to the Novice Eye The typical cis-AB phenotype shows weaker-than-expected expression of one or both antigens, which can lead to misclassification during routine testing. If the wrong type is assigned, a transfusion mismatch can result, with potentially serious consequences.
On the Rh side, things can also get complicated. Some people have a “weak D” or “partial D” phenotype, where the RhD protein is present but at lower levels or in an altered form. Standard blood typing reagents may or may not detect it, leading to inconsistent results. Molecular testing can identify the specific gene variant responsible, which matters for both transfusion decisions and pregnancy management.16PubMed. Weak or partial D: Importance of molecular characterization of D variants Someone classified as “Rh negative” on one test could show a weak positive on another, depending on the sensitivity of the method used. For most people this never becomes an issue, but for patients who need repeated transfusions or for pregnant women, the distinction can matter clinically.
Enzymatic Conversion and the Future of Blood Supply
One of the more creative approaches to the perpetual shortage of rare blood types involves converting A, B, and AB blood into something that behaves like type O. The idea is to use enzymes as molecular scissors that clip the sugar molecules off red blood cell surfaces, removing the A and B antigens entirely. Researchers have produced recombinant versions of three enzymes in bacteria and confirmed that enzyme-mediated blood type conversion works in the lab, removing ABO incompatibility and theoretically expanding the pool of universal donor blood.17PubMed Central. Expression and functional evaluation of recombinant human ABO blood group antigen cleaving glycoside hydrolases α-N-acetylgalactosaminidase, α-galactosidase, and endo-β-galactosidase produced in Escherichia coli
If this technology matures to clinical use, it could reshape how blood banks operate. Rather than struggling to match rare types like AB negative, hospitals could enzymatically strip any donated unit and use it universally. The approach is still experimental, and major hurdles remain around efficiency, cost, and ensuring complete antigen removal at scale. But it represents a fundamentally different way of thinking about blood supply, one that could make the rarity of AB negative medically irrelevant even if the type itself remains genetically uncommon. For now, though, people with AB negative blood who want to contribute to the supply are still best served by donating plasma, where their type has outsized value as a universal product that any patient can receive in an emergency.